Skip to main content

Hepatitis B Prevention News

Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults

BERKELEY, CA – (Marketwired) – November 9, 2017 – Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Vaccination and Prophlaxis